World's Best Scientists 2026 revealed!
Bertrand Cariou

Bertrand Cariou

D-Index & Metrics

Medicine

D-Index
79
Citations
24443
World Ranking
17499
National Ranking
582

Bertrand Cariou publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bertrand Cariou sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 621 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bertrand Cariou D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bertrand Cariou sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bertrand Cariou is affiliated with the University of Nantes in France. Their research spans multiple fields with a primary focus on Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, their significant subfields of study include Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine, and Epidemiology.

Their scientific work covers a range of topics centered around metabolic and cardiovascular health. Main topics documented in their publications include Lipoproteins and Cardiovascular Health, Diabetes Treatment and Management, Liver Disease Diagnosis and Treatment, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipid metabolism and disorders, COVID-19 Clinical Research Studies, and Metabolism, Diabetes, and Cancer.

Bertrand Cariou has contributed to numerous papers, among which key publications are:

  • Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study, 2020, Diabetologia
  • Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study, 2021, Diabetologia
  • Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review, 2021, Diabetes Obesity and Metabolism

Other notable publications in the wider research community relevant to related topics include works on lipid management, metabolic dysregulation in obesity and diabetes, and metabolic disease reviews published in journals such as The Journal of Clinical Endocrinology & Metabolism and The Journal of Experimental Medicine.

Their research outputs have appeared frequently in several scientific journals. The most prolific publication venues include:

  • Atherosclerosis
  • Diabetes & Metabolism
  • Diabetes Obesity and Metabolism
  • Journal of Hepatology
  • Arteriosclerosis Thrombosis and Vascular Biology

Collaboration has been a substantial part of their career. Frequent coauthors include Cédric Le May, Samy Hadjadj, Mikaël Croyal, Matthieu Wargny, and Mathilde Di Filippo, reflecting ongoing partnerships in related areas of research.

Best Publications

  • Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation

    Philippe Lefebvre;Bertrand Cariou;Fleur Lien;Folkert Kuipers

  • PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2) : a randomised, double-blind, placebo-controlled trial

    Frederick J Raal;Evan A Stein;Robert Dufour;Traci Turner

  • Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.

    Bertrand Cariou;Samy Hadjadj;Matthieu Wargny;Matthieu Pichelin

  • The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice

    Bertrand Cariou;Bertrand Cariou;Bertrand Cariou;Kirsten Van Harmelen;Kirsten Van Harmelen;Kirsten Van Harmelen;Daniel Duran-Sandoval;Daniel Duran-Sandoval;Daniel Duran-Sandoval;Theo H. Van Dijk

  • Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

    J-F Yale;G Bakris;B Cariou;D Yue

  • Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

    Christopher P. Cannon;Bertrand Cariou;Dirk Blom;James M. McKenney

  • Thiazolidinediones and PPARγ agonists: time for a reassessment

    Bertrand Cariou;Bertrand Cariou;Bernard Charbonnel;Bart Staels;Bart Staels

  • Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

    Bernard Zinman;Athena Philis-Tsimikas;Bertrand Cariou;Yehuda Handelsman

  • Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial

    Vanita R Aroda;Stephen C Bain;Bertrand Cariou;Milivoj Piletič

  • PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

    Amand F Schmidt;Daniel I Swerdlow;Daniel I Swerdlow;Michael V Holmes;Michael V Holmes;Riyaz S Patel;Riyaz S Patel

  • Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c

    Philippe Costet;Bertrand Cariou;Gilles Lambert;Florent Lalanne

  • Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

    Bart Staels;Anne Rubenstrunk;Benoit Noel;Géraldine Rigou

  • Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity

    Janne Prawitt;Mouaadh Abdelkarim;Johanna H.M. Stroeve;Iuliana Popescu

  • Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

    Paresh Dandona;Chantal Mathieu;Moshe Phillip;Lars Hansen

  • International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors

    Thomas Danne;Satish Garg;Anne L. Peters;John B. Buse

  • Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.

    J.-F. Yale;G. Bakris;B. Cariou;J. Nieto

  • The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism during the Fasting-Refeeding Transition

    Daniel Duran-Sandoval;Bertrand Cariou;Fredéric Percevault;Nathalie Hennuyer

  • Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects

    Bertrand Cariou;Rémy Hanf;Stéphanie Lambert-Porcheron;Yassine Zaïr

  • Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

    Paresh Dandona;Chantal Mathieu;Moshe Phillip;Lars Hansen

  • Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

    Bernard Zinman;Vanita R. Aroda;Vanita R. Aroda;John B. Buse;Bertrand Cariou

Frequent Co-Authors

Bart Staels
Bart Staels University of Lille
Folkert Kuipers
Folkert Kuipers University Medical Center Groningen
Helen M. Colhoun
Helen M. Colhoun University of Edinburgh
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto
Robert R. Henry
Robert R. Henry University of California, San Diego
Michel Marre
Michel Marre Université Paris Cité
Fabrice Bonnet
Fabrice Bonnet University of Rennes
Satish K. Garg
Satish K. Garg University of Colorado Anschutz Medical Campus
Jérôme Bertherat
Jérôme Bertherat Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering careers in medicine, there are numerous alternative routes and online programs that can help accelerate your healthcare journey. Many opt for nursing degrees due to their high demand and flexible learning options. For those already holding an RN license and seeking advancement, exploring the online nursing doctorate can lead to advanced roles in clinical leadership, education, or research.

Cost is a significant factor for most students. Thankfully, the cheapest rn to bsn program online options make it easier for practicing nurses to continue their education without a large financial burden.

Aspiring nurses without previous nursing experience or degree should look into direct entry msn programs for non nurses online. These accelerated online programs provide a direct path to a master’s in nursing, even for those coming from unrelated fields.

If you’re seeking less competitive admissions, there are resources highlighting the easiest nursing schools to get into, helping you identify programs that match your qualifications and career goals.

Best Scientists Citing Bertrand Cariou

Trending Scientists

Recently Published Articles